Ngā hua rapu - David E. Heppner
- E whakaatu ana i te 1 - 20 hua o te 27
- Haere ki te Whārangi Whai Ake
-
1
Lazertinib: Breaking the mold of third-generation EGFR inhibitors mā Kishan B. Patel, David E. Heppner
I whakaputaina 2025Revisão -
2
Redox-dependent regulation of epidermal growth factor receptor signaling mā David E. Heppner, Albert van der Vliet
I whakaputaina 2015Revisão -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Architecture of the NADPH oxidase family of enzymes mā Blessing C. Ogboo, Uriy V. Grabovyy, Aniket Maini, Scott Scouten, Albert van der Vliet, Andrea Mattevi, David E. Heppner
I whakaputaina 2022Revisão -
12
Pitfalls and Considerations in Determining the Potency and Mutant Selectivity of Covalent Epidermal Growth Factor Receptor Inhibitors mā Kristopher W. Hoyt, Daniel A. Urul, Blessing C. Ogboo, Florian Wittlinger, Stefan Laufer, Erik Schaefer, Earl W. May, David E. Heppner
I whakaputaina 2023Artigo -
13
DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties mā Andrew C. Little, Derek Sham, Milena Hristova, Karamatullah Danyal, David E. Heppner, R Bauer, Lynn Sipsey, Aida Habibovic, Albert van der Vliet
I whakaputaina 2016Artigo -
14
-
15
Cysteine perthiosulfenic acid (Cys-SSOH): A novel intermediate in thiol-based redox signaling? mā David E. Heppner, Milena Hristova, Tomoaki Ida, Ana Mijušković, Christopher M. Dustin, Virág Bogdándi, Jon M. Fukuto, Tobias P. Dick, Péter Nagy, Jianing Li, Takaaki Akaike, Albert van der Vliet
I whakaputaina 2017Artigo -
16
Direct cysteine sulfenylation drives activation of the Src kinase mā David E. Heppner, Christopher M. Dustin, Chenyi Liao, Milena Hristova, Carmen Veith, Andrew C. Little, Bethany A. Ahlers, Sheryl L. White, Bin Deng, Ying‐Wai Lam, Jianing Li, Albert van der Vliet
I whakaputaina 2018Artigo -
17
Lung epithelial protein disulfide isomerase A3 (PDIA3) plays an important role in influenza infection, inflammation, and airway mechanics mā Nicolas Chamberlain, Bethany R. Korwin-Mihavics, Emily M. Nakada, S. Bruno, David E. Heppner, David G. Chapman, Sidra M. Hoffman, Albert van der Vliet, Benjamin T. Suratt, Oliver Dienz, John F. Alcorn, Vikas Anathy
I whakaputaina 2019Artigo -
18
Molecular basis for cooperative binding and synergy of ATP-site and allosteric EGFR inhibitors mā Tyler S. Beyett, Ciric To, David E. Heppner, Jaimin K. Rana, Anna M. Schmoker, Jaebong Jang, Dries J.H. De Clercq, Gabriel Gómez, David A. Scott, Nathanael S. Gray, Pasi A. Jänne, Michael J. Eck
I whakaputaina 2022Artigo -
19
DUOX1 mediates persistent epithelial EGFR activation, mucous cell metaplasia, and airway remodeling during allergic asthma mā Aida Habibovic, Milena Hristova, David E. Heppner, Karamatullah Danyal, Jennifer L. Ather, Yvonne Janssen‐Heininger, Charles G. Irvin, Matthew E. Poynter, Lennart K. A. Lundblad, Anne E. Dixon, Miklós Geiszt, Albert van der Vliet
I whakaputaina 2016Artigo -
20
Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors mā Dries J.H. De Clercq, David E. Heppner, Ciric To, Jaebong Jang, Eunyoung Park, Cai‐Hong Yun, Mierzhati Mushajiang, Bo Hee Shin, Thomas W. Gero, David A. Scott, Pasi A. Jänne, Michael J. Eck, Nathanael S. Gray
I whakaputaina 2019Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Biochemistry
Chemistry
Epidermal growth factor receptor
Receptor
Enzyme
Gene
Cancer research
Cell biology
EGFR inhibitors
Organic chemistry
Cancer
Mutant
Allosteric regulation
Gefitinib
Genetics
Medicine
T790M
Tyrosine kinase
Computational biology
Erlotinib
Internal medicine
Kinase
Reactive oxygen species
Signal transduction
Stereochemistry
Biophysics
Combinatorial chemistry
Cysteine
NADPH oxidase